Analysis of SARS-CoV-2 Spike Protein Variants with Recombinant Reporter Viruses Created from a Bacmid System
暂无分享,去创建一个
[1] Z. Meshkat,et al. Mutations in SARS-CoV-2 structural proteins: a global analysis , 2022, Virology journal.
[2] William T. Harvey,et al. SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway , 2022, Nature Microbiology.
[3] Y. Kamatani,et al. SARS-CoV-2 ORF6 disrupts nucleocytoplasmic trafficking to advance viral replication , 2022, Communications Biology.
[4] M. Neurath,et al. SMYD2 Inhibition Downregulates TMPRSS2 and Decreases SARS-CoV-2 Infection in Human Intestinal and Airway Epithelial Cells , 2022, Cells.
[5] F. Kirchhoff,et al. Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning? , 2022, Journal of virology.
[6] L. Poon,et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo , 2022, Nature.
[7] A. Kaneda,et al. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant , 2022, Nature.
[8] C. Zheng,et al. Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines , 2022, Journal of medical virology.
[9] C. Sturmbauer,et al. The mutational dynamics of the SARS-CoV-2 virus in serial passages in vitro , 2022, Virologica Sinica.
[10] T. Ndung’u,et al. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization , 2021, Nature.
[11] P. Maes,et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization , 2021, Nature.
[12] Fei Shao,et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies , 2021, bioRxiv.
[13] Liyuan Liu,et al. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2 , 2021, Nature.
[14] Y. Kawaoka,et al. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation , 2021, Nature.
[15] M. Farzan,et al. Mechanisms of SARS-CoV-2 entry into cells , 2021, Nature reviews. Molecular cell biology.
[16] K. Überla,et al. Cloning of a Passage-Free SARS-CoV-2 Genome and Mutagenesis Using Red Recombination , 2021, International journal of molecular sciences.
[17] Xiaomin Zeng,et al. Molecular evolutionary characteristics of SARS‐CoV‐2 emerging in the United States , 2021, Journal of medical virology.
[18] Foad Alzoughool,et al. New SARS-CoV-2 Variant from Jordan , 2021, Microbiology resource announcements.
[19] P. Maes,et al. Variant Analysis of SARS-CoV-2 Genomes from Belgian Military Personnel Engaged in Overseas Missions and Operations , 2021, Viruses.
[20] H. Mouquet,et al. SARS-CoV-2 Alpha, Beta and Delta variants display enhanced Spike-mediated Syncytia Formation , 2021, bioRxiv.
[21] William T. Harvey,et al. SARS-CoV-2 variants, spike mutations and immune escape , 2021, Nature Reviews Microbiology.
[22] W. Doerfler,et al. SARS‐CoV‐2 worldwide replication drives rapid rise and selection of mutations across the viral genome: a time‐course study – potential challenge for vaccines and therapies , 2021, medRxiv.
[23] Vineet D. Menachery,et al. Spike mutation D614G alters SARS-CoV-2 fitness , 2020, Nature.
[24] S. Pongor,et al. Different mutations in SARS-CoV-2 associate with severe and mild outcome , 2020, International Journal of Antimicrobial Agents.
[25] W. Doerfler,et al. Signal hotspot mutations in SARS-CoV-2 genomes evolve as the virus spreads and actively replicates in different parts of the world , 2020, Virus Research.
[26] F. Klawonn,et al. Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases , 2020, Journal of virology.
[27] E. Hartenian,et al. The molecular virology of coronaviruses , 2020, The Journal of Biological Chemistry.
[28] R. Matyášek,et al. Mutation Patterns of Human SARS-CoV-2 and Bat RaTG13 Coronavirus Genomes Are Strongly Biased Towards C>U Transitions, Indicating Rapid Evolution in Their Hosts , 2020, Genes.
[29] S. Rowland-Jones,et al. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus , 2020, Cell.
[30] A. Shehata,et al. The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control , 2020, Journal of clinical medicine.
[31] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[32] G. Gao,et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.
[33] E. Decroly,et al. One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities , 2014, Proceedings of the National Academy of Sciences.
[34] Lisa E. Gralinski,et al. Release of Severe Acute Respiratory Syndrome Coronavirus Nuclear Import Block Enhances Host Transcription in Human Lung Cells , 2013, Journal of Virology.